In addition, the expression of both HIF-1α and HIF1A-AS2 is upregulated in cisplatin-resistant bladder cancer cells (CRBC cells), denoting that HIF1A-AS2 can be regulated by HIF-1α in drug-resistant cells [55]. This evidence concerns the gene HIF1A and urinary bladder carcinoma.